about
The past, present, and future of monoclonal antibodies to IL-5 and eosinophilic asthma: a review.Asthma across the ages: knowledge gaps in childhood asthmaAdd-on LABA in a separate inhaler as asthma step-up therapy versus increased dose of ICS or ICS/LABA combination inhalerAn official American Thoracic Society Workshop Report: presentations and discussion of the fifth Jack Pepys Workshop on Asthma in the Workplace. Comparisons between asthma in the workplace and non-work-related asthma.Decision-making analysis for allergen immunotherapy versus nasal steroids in the treatment of nasal steroid-responsive allergic rhinitis.Anti-inflammatory and corticosteroid-enhancing actions of vitamin D in monocytes of patients with steroid-resistant and those with steroid-sensitive asthma.An official American Thoracic Society research statement: comparative effectiveness research in pulmonary, critical care, and sleep medicine.Defining emergency department asthma visits for public health surveillance, North Carolina, 2008-2009.Interventions to modify health care provider adherence to asthma guidelines: a systematic review.Obesity and asthma: pathophysiology and implications for diagnosis and management in primary careSocioeconomic status and asthma control in African American youth in SAGE II.Cyclic AMP concentrations in dendritic cells induce and regulate Th2 immunity and allergic asthma.Cost-effectiveness of initiating extrafine- or standard size-particle inhaled corticosteroid for asthma in two health-care systems: a retrospective matched cohort study.The economic burden of adult asthma in Cyprus; a prevalence-based cost of illness study.Phase 2, randomised placebo-controlled trial to evaluate the efficacy and safety of an anti-GM-CSF antibody (KB003) in patients with inadequately controlled asthmaFluticasone propionate pharmacogenetics: CYP3A4*22 polymorphism and pediatric asthma control.Cost comparison of asthma treatments in 12-week study: caution about matching and short observational follow-up.The asthma prediction rule to decrease hospitalizations for children with asthma.Cost-effectiveness of asthma therapy: a comprehensive review.Development of School-Based Asthma Management Programs in Rochester, New York: Presented in Honor of Dr Robert Haggerty.Design of a pragmatic trial in minority children presenting to the emergency department with uncontrolled asthma: The CHICAGO Plan.Developing core economic outcome sets for asthma studies: a protocol for a systematic review.IRF5 distinguishes severe asthma in humans and drives Th1 phenotype and airway hyperreactivity in miceAsthma in USA: its impact on health-related quality of life.Evaluation of a Pilot Asthma Care Program for Electronic Communication between School Health and a Healthcare System's Electronic Medical RecordRandomized trial of a health communication intervention for parents of children with asthma.Spatiotemporal patterns of childhood asthma hospitalization and utilization in Memphis Metropolitan Area from 2005 to 2015.Severe asthma in humans and mouse model suggests a CXCL10 signature underlies corticosteroid-resistant Th1 bias.Increased Dose of Inhaled Corticosteroid versus Add-On Long-acting β-Agonist for Step-Up Therapy in Asthma.Significant association between GSTT1 null genotype and risk of asthma during childhood in Caucasians.Chronic disease co-morbidity of asthma and unscheduled asthma care among adults: results of the national telephone health interview survey German Health Update (GEDA) 2009 and 2010.Disparities in assessments of asthma control between children, parents, and physicians.The School Inner-City Asthma Intervention Study: Design, rationale, methods, and lessons learned.An integrated operational definition and conceptual model of asthma self-management in teens.Results of an asthma education program delivered via telemedicine in rural schools.Patient and Family Engagement in the Design of a Mobile Health Solution for Pediatric Asthma: Development and Feasibility Study.
P2860
Q26775861-143C1EE1-D24A-4603-9D5C-7DBAECA60A6DQ26821787-6D456010-BF2F-44D5-8D23-9A97534A97DAQ28596628-3DD741E4-B810-48D3-9F7C-3894409A2F46Q30352328-37B1D59F-B8B3-4274-A292-B28B0840CDEEQ30415158-DD5F7507-AF3E-4652-B4D3-348D62D10278Q33693320-A0C06A93-60EA-4031-9992-C4FF0204B43FQ33735726-6A4EE99F-DAE4-4C1A-A3B2-D9FAF81D1581Q33768360-D50E8340-DFEB-4A8F-8444-58FB09359552Q33837054-8F12F2B5-CAC0-47BB-883E-41FA74792FEDQ34505916-8B1626A3-3C6A-457A-B1E6-A27143D29F0CQ34637595-634B4EA9-30E8-4C66-8971-315C67666F52Q35062625-34990120-8880-417A-8A64-5E782E23B5C5Q35216441-F2FF71CD-C9B5-4C24-8BE0-2F4B757630B2Q36311225-B235877D-41C4-479C-ACDF-63474BC5931FQ36472094-F2868EAD-A391-4330-9517-2E3C9D7D9F26Q36750899-3471A80A-C849-43FF-BE22-743781C6A4B1Q37387365-82BEA42E-91F0-47AD-BCCA-8085DA3F9162Q37737143-0E4CA2A5-D020-47B8-962A-27200BAA0D27Q38300002-954AB093-07EC-4890-B648-12D8582F43BCQ38371206-DF99B88F-CF17-46FD-AD0D-849CB1FDEF5CQ38371726-981CF2BD-8048-46C2-84C0-63BC2A488E06Q38628229-B0CC85B1-4BB2-42BF-B092-783513782D5CQ38780046-827C3F81-2CD0-4440-94FE-3E321E0DD921Q39224597-7DA0AE59-003A-4959-BD65-36DCD69C06ABQ39273510-08151051-D899-4812-85C9-489D298C459EQ40201462-9333F751-9916-4E48-8668-778D440E1BC0Q40432952-5570DFC4-789F-48C8-99C2-134D94D417A0Q40952721-F52C804E-2E6C-4788-8996-D5C9F04BA97DQ41256329-1FFEB673-C2C3-43DD-9DCA-6DE08D6BE741Q43408613-EFA66E30-7C6E-4479-AFDA-790B1A0A733EQ43943115-3601D5B2-D669-4F57-8511-EF0FA73C57CAQ44270418-3FA6C0D3-B9C8-4BA1-8E3D-76B00FC075BCQ47344638-B607402B-F3B1-4001-839F-61BFDD4D3F51Q47557057-46EB02CD-41A7-4633-AE63-8679CB6200F3Q51409081-F7BECD68-376C-44E1-BC96-5DD2C4D32799Q52641941-FA2BF036-EB8A-4801-901D-9636AC373253
P2860
description
2012 nî lūn-bûn
@nan
2012 թուականի Մարտին հրատարակուած գիտական յօդուած
@hyw
2012 թվականի մարտին հրատարակված գիտական հոդված
@hy
2012年の論文
@ja
2012年論文
@yue
2012年論文
@zh-hant
2012年論文
@zh-hk
2012年論文
@zh-mo
2012年論文
@zh-tw
2012年论文
@wuu
name
Asthma outcomes: healthcare utilization and costs
@ast
Asthma outcomes: healthcare utilization and costs
@en
Asthma outcomes: healthcare utilization and costs
@nl
type
label
Asthma outcomes: healthcare utilization and costs
@ast
Asthma outcomes: healthcare utilization and costs
@en
Asthma outcomes: healthcare utilization and costs
@nl
prefLabel
Asthma outcomes: healthcare utilization and costs
@ast
Asthma outcomes: healthcare utilization and costs
@en
Asthma outcomes: healthcare utilization and costs
@nl
P2093
P2860
P1476
Asthma outcomes: healthcare utilization and costs
@en
P2093
Jonathan D Campbell
Lara J Akinbami
Robert A Smith
Robert W Grundmeier
Sean D Sullivan
Tina V Hartert
P2860
P304
P356
10.1016/J.JACI.2011.12.984
P407
P433
P50
P577
2012-03-01T00:00:00Z